Benign Prostatic Hyperplasia: Innovations in Management
A symposium on benign prostatic hyperplasia is appropriate at a time when new knowledge and new technology are rapidly emerging. As the age of the population has increased and diagnostic methods have improved, the incidence of diseases of the prostate has increased. Benign prostatic hyperplasia (BPH...
Gespeichert in:
Weitere Verfasser: | , |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Berlin, Heidelberg
Springer Berlin Heidelberg
1994
|
Schlagworte: | |
Online-Zugang: | UBR01 Volltext |
Zusammenfassung: | A symposium on benign prostatic hyperplasia is appropriate at a time when new knowledge and new technology are rapidly emerging. As the age of the population has increased and diagnostic methods have improved, the incidence of diseases of the prostate has increased. Benign prostatic hyperplasia (BPH) is the most common benign tumor in men and results in urinary symptoms in the majority of men older than 50 years; furthermore it has in the past necessitated operative intervention in 20%-30% of men who live to the age of 80 years. The relief of obstruction resulting from this benign neoplasm by means of transurethral resection (TURP) or surgical enucleation represented a major advance and helped to establish urology as a major surgical science. Over the years, urologists became more and more proficient with the resectoscope, reducing the need for open surgery, and over time more procedures were done for more modest symptoms. Although unquestionably effective in the relief of bladder outlet obstruction in the majority of men treated, TURP has not been without morbidity. In 1989, the American Urological Association (AUA) reported an 18% im mediate postoperative morbidity in its cooperative study of 13 participating institutions evaluating 3885 patients (MEBUST et al. 1989). Included were patients requiring transfusion, those experiencing excessive absorption of irrigating fluids ("TUR syndrome"), those experiencing myocardial arrhythmias, and a few suffer ing myocardial infarction |
Beschreibung: | 1 Online-Ressource (XII, 384 p) |
ISBN: | 9783642781858 |
DOI: | 10.1007/978-3-642-78185-8 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV046144250 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 190905s1994 |||| o||u| ||||||eng d | ||
020 | |a 9783642781858 |9 978-3-642-78185-8 | ||
024 | 7 | |a 10.1007/978-3-642-78185-8 |2 doi | |
035 | |a (ZDB-2-SME)978-3-642-78185-8 | ||
035 | |a (OCoLC)1119011730 | ||
035 | |a (DE-599)BVBBV046144250 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-355 | ||
082 | 0 | |a 616.6 |2 23 | |
084 | |a YK 9515 |0 (DE-625)153807:12921 |2 rvk | ||
245 | 1 | 0 | |a Benign Prostatic Hyperplasia |b Innovations in Management |c edited by Zbigniew Petrovich, Luc Baert |
264 | 1 | |a Berlin, Heidelberg |b Springer Berlin Heidelberg |c 1994 | |
300 | |a 1 Online-Ressource (XII, 384 p) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
520 | |a A symposium on benign prostatic hyperplasia is appropriate at a time when new knowledge and new technology are rapidly emerging. As the age of the population has increased and diagnostic methods have improved, the incidence of diseases of the prostate has increased. Benign prostatic hyperplasia (BPH) is the most common benign tumor in men and results in urinary symptoms in the majority of men older than 50 years; furthermore it has in the past necessitated operative intervention in 20%-30% of men who live to the age of 80 years. The relief of obstruction resulting from this benign neoplasm by means of transurethral resection (TURP) or surgical enucleation represented a major advance and helped to establish urology as a major surgical science. Over the years, urologists became more and more proficient with the resectoscope, reducing the need for open surgery, and over time more procedures were done for more modest symptoms. Although unquestionably effective in the relief of bladder outlet obstruction in the majority of men treated, TURP has not been without morbidity. In 1989, the American Urological Association (AUA) reported an 18% im mediate postoperative morbidity in its cooperative study of 13 participating institutions evaluating 3885 patients (MEBUST et al. 1989). Included were patients requiring transfusion, those experiencing excessive absorption of irrigating fluids ("TUR syndrome"), those experiencing myocardial arrhythmias, and a few suffer ing myocardial infarction | ||
650 | 4 | |a Urology | |
650 | 4 | |a Endocrinology | |
650 | 4 | |a Surgery | |
650 | 4 | |a Urology | |
650 | 4 | |a Endocrinology | |
650 | 4 | |a Surgery | |
650 | 0 | 7 | |a Prostatahypertrophie |0 (DE-588)4137018-1 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Therapie |0 (DE-588)4059798-2 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
689 | 0 | 0 | |a Prostatahypertrophie |0 (DE-588)4137018-1 |D s |
689 | 0 | 1 | |a Therapie |0 (DE-588)4059798-2 |D s |
689 | 0 | |5 DE-604 | |
700 | 1 | |a Petrovich, Zbigniew |4 edt | |
700 | 1 | |a Baert, Luc |4 edt | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783540566281 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783642781872 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783642781865 |
856 | 4 | 0 | |u https://doi.org/10.1007/978-3-642-78185-8 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
912 | |a ZDB-2-SME | ||
940 | 1 | |q ZDB-2-SME_1990/2004 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-031524435 | ||
966 | e | |u https://doi.org/10.1007/978-3-642-78185-8 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804180479413321728 |
---|---|
any_adam_object | |
author2 | Petrovich, Zbigniew Baert, Luc |
author2_role | edt edt |
author2_variant | z p zp l b lb |
author_facet | Petrovich, Zbigniew Baert, Luc |
building | Verbundindex |
bvnumber | BV046144250 |
classification_rvk | YK 9515 |
collection | ZDB-2-SME |
ctrlnum | (ZDB-2-SME)978-3-642-78185-8 (OCoLC)1119011730 (DE-599)BVBBV046144250 |
dewey-full | 616.6 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616.6 |
dewey-search | 616.6 |
dewey-sort | 3616.6 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
doi_str_mv | 10.1007/978-3-642-78185-8 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03539nmm a2200565zc 4500</leader><controlfield tag="001">BV046144250</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s1994 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783642781858</subfield><subfield code="9">978-3-642-78185-8</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-642-78185-8</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-3-642-78185-8</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1119011730</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046144250</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.6</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YK 9515</subfield><subfield code="0">(DE-625)153807:12921</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Benign Prostatic Hyperplasia</subfield><subfield code="b">Innovations in Management</subfield><subfield code="c">edited by Zbigniew Petrovich, Luc Baert</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin, Heidelberg</subfield><subfield code="b">Springer Berlin Heidelberg</subfield><subfield code="c">1994</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XII, 384 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">A symposium on benign prostatic hyperplasia is appropriate at a time when new knowledge and new technology are rapidly emerging. As the age of the population has increased and diagnostic methods have improved, the incidence of diseases of the prostate has increased. Benign prostatic hyperplasia (BPH) is the most common benign tumor in men and results in urinary symptoms in the majority of men older than 50 years; furthermore it has in the past necessitated operative intervention in 20%-30% of men who live to the age of 80 years. The relief of obstruction resulting from this benign neoplasm by means of transurethral resection (TURP) or surgical enucleation represented a major advance and helped to establish urology as a major surgical science. Over the years, urologists became more and more proficient with the resectoscope, reducing the need for open surgery, and over time more procedures were done for more modest symptoms. Although unquestionably effective in the relief of bladder outlet obstruction in the majority of men treated, TURP has not been without morbidity. In 1989, the American Urological Association (AUA) reported an 18% im mediate postoperative morbidity in its cooperative study of 13 participating institutions evaluating 3885 patients (MEBUST et al. 1989). Included were patients requiring transfusion, those experiencing excessive absorption of irrigating fluids ("TUR syndrome"), those experiencing myocardial arrhythmias, and a few suffer ing myocardial infarction</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Urology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Endocrinology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Surgery</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Urology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Endocrinology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Surgery</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Prostatahypertrophie</subfield><subfield code="0">(DE-588)4137018-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Prostatahypertrophie</subfield><subfield code="0">(DE-588)4137018-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Petrovich, Zbigniew</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Baert, Luc</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783540566281</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783642781872</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783642781865</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-3-642-78185-8</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031524435</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-3-642-78185-8</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
genre | (DE-588)1071861417 Konferenzschrift gnd-content (DE-588)4143413-4 Aufsatzsammlung gnd-content |
genre_facet | Konferenzschrift Aufsatzsammlung |
id | DE-604.BV046144250 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T08:36:25Z |
institution | BVB |
isbn | 9783642781858 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031524435 |
oclc_num | 1119011730 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR |
owner_facet | DE-355 DE-BY-UBR |
physical | 1 Online-Ressource (XII, 384 p) |
psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
publishDate | 1994 |
publishDateSearch | 1994 |
publishDateSort | 1994 |
publisher | Springer Berlin Heidelberg |
record_format | marc |
spelling | Benign Prostatic Hyperplasia Innovations in Management edited by Zbigniew Petrovich, Luc Baert Berlin, Heidelberg Springer Berlin Heidelberg 1994 1 Online-Ressource (XII, 384 p) txt rdacontent c rdamedia cr rdacarrier A symposium on benign prostatic hyperplasia is appropriate at a time when new knowledge and new technology are rapidly emerging. As the age of the population has increased and diagnostic methods have improved, the incidence of diseases of the prostate has increased. Benign prostatic hyperplasia (BPH) is the most common benign tumor in men and results in urinary symptoms in the majority of men older than 50 years; furthermore it has in the past necessitated operative intervention in 20%-30% of men who live to the age of 80 years. The relief of obstruction resulting from this benign neoplasm by means of transurethral resection (TURP) or surgical enucleation represented a major advance and helped to establish urology as a major surgical science. Over the years, urologists became more and more proficient with the resectoscope, reducing the need for open surgery, and over time more procedures were done for more modest symptoms. Although unquestionably effective in the relief of bladder outlet obstruction in the majority of men treated, TURP has not been without morbidity. In 1989, the American Urological Association (AUA) reported an 18% im mediate postoperative morbidity in its cooperative study of 13 participating institutions evaluating 3885 patients (MEBUST et al. 1989). Included were patients requiring transfusion, those experiencing excessive absorption of irrigating fluids ("TUR syndrome"), those experiencing myocardial arrhythmias, and a few suffer ing myocardial infarction Urology Endocrinology Surgery Prostatahypertrophie (DE-588)4137018-1 gnd rswk-swf Therapie (DE-588)4059798-2 gnd rswk-swf (DE-588)1071861417 Konferenzschrift gnd-content (DE-588)4143413-4 Aufsatzsammlung gnd-content Prostatahypertrophie (DE-588)4137018-1 s Therapie (DE-588)4059798-2 s DE-604 Petrovich, Zbigniew edt Baert, Luc edt Erscheint auch als Druck-Ausgabe 9783540566281 Erscheint auch als Druck-Ausgabe 9783642781872 Erscheint auch als Druck-Ausgabe 9783642781865 https://doi.org/10.1007/978-3-642-78185-8 Verlag URL des Erstveröffentlichers Volltext |
spellingShingle | Benign Prostatic Hyperplasia Innovations in Management Urology Endocrinology Surgery Prostatahypertrophie (DE-588)4137018-1 gnd Therapie (DE-588)4059798-2 gnd |
subject_GND | (DE-588)4137018-1 (DE-588)4059798-2 (DE-588)1071861417 (DE-588)4143413-4 |
title | Benign Prostatic Hyperplasia Innovations in Management |
title_auth | Benign Prostatic Hyperplasia Innovations in Management |
title_exact_search | Benign Prostatic Hyperplasia Innovations in Management |
title_full | Benign Prostatic Hyperplasia Innovations in Management edited by Zbigniew Petrovich, Luc Baert |
title_fullStr | Benign Prostatic Hyperplasia Innovations in Management edited by Zbigniew Petrovich, Luc Baert |
title_full_unstemmed | Benign Prostatic Hyperplasia Innovations in Management edited by Zbigniew Petrovich, Luc Baert |
title_short | Benign Prostatic Hyperplasia |
title_sort | benign prostatic hyperplasia innovations in management |
title_sub | Innovations in Management |
topic | Urology Endocrinology Surgery Prostatahypertrophie (DE-588)4137018-1 gnd Therapie (DE-588)4059798-2 gnd |
topic_facet | Urology Endocrinology Surgery Prostatahypertrophie Therapie Konferenzschrift Aufsatzsammlung |
url | https://doi.org/10.1007/978-3-642-78185-8 |
work_keys_str_mv | AT petrovichzbigniew benignprostatichyperplasiainnovationsinmanagement AT baertluc benignprostatichyperplasiainnovationsinmanagement |